Research Overview
CJC-1295 (No DAC) + Ipamorelin combines two research peptides associated with growth-hormone signaling and is primarily researched in connection with GH release, IGF-1 signaling, recovery-related biology, body composition, and metabolic research.
Quality & Testing
Novanix Labs evaluates compounds for purity, mass, and identity as part of our quality-assurance process. Analytical testing is used to verify compound identity, assess chemical purity, and confirm the amount of material present. Testing documentation is maintained as part of our commitment to consistency, transparency, and research standards.
Additional Research Information
The components approach growth-hormone signaling through complementary mechanisms: Ipamorelin acts through the growth-hormone secretagogue receptor while CJC-related GHRH analogues target the growth-hormone-releasing hormone pathway.